DS
SGYP

David Shaw’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

David Shaw’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-13,359
Closed -$2K – 4101
2018
Q4 		$2K Sell
13,359
-155,505
-92% -$102K ﹤0.01% 3720
2018
Q3 		$287K Buy
+168,864
New +$302K ﹤0.01% 3378
2018
Q1 		– Sell
-28,964
Closed -$65K – 3918
2017
Q4 		$65K Sell
28,964
-6,385
-18% -$15.9K ﹤0.01% 3520
2017
Q3 		$103K Sell
35,349
-11,310
-24% -$38.6K ﹤0.01% 3364
2017
Q2 		$208K Sell
46,659
-20,486
-31% -$84.5K ﹤0.01% 3180
2017
Q1 		$313K Sell
67,145
-149,093
-69% -$865K ﹤0.01% 2952
2016
Q4 		$1.32M Buy
216,238
+28,027
+15% +$147K ﹤0.01% 2293
2016
Q3 		$1.04M Buy
188,211
+109,736
+140% +$514K ﹤0.01% 2362
2016
Q2 		$298K Buy
+78,475
New +$266K ﹤0.01% 3020

Other funds holding SGYP

TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

David Shaw's SGYP Position: Q1 2019 in Review

David Shaw sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 13,359 shares — an estimated $2K sold.

David Shaw first reported a position in SGYP in Q2 2016 and held it in 9 quarters. The position peaked at $1.32M in Q4 2016. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.

  • David Shaw reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
  • David Shaw sold 13,359 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $2K.
  • David Shaw first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2016 and held it in 9 quarters.
  • David Shaw's Synergy Pharmaceuticals, Inc Common Stock position peaked at $1.32M in Q4 2016.
  • 12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.

Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.